A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 3,193,654 shares of PFE stock, worth $89.4 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
3,193,654
Previous 3,226,955 1.03%
Holding current value
$89.4 Million
Previous $92.9 Million 4.61%
% of portfolio
0.29%
Previous 0.33%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$25.89 - $29.73 $862,162 - $990,038
-33,301 Reduced 1.03%
3,193,654 $88.6 Million
Q4 2023

Jan 24, 2024

SELL
$26.13 - $33.94 $546,378 - $709,685
-20,910 Reduced 0.64%
3,226,955 $92.9 Million
Q3 2023

Oct 23, 2023

SELL
$32.09 - $37.51 $2.42 Million - $2.83 Million
-75,422 Reduced 2.27%
3,247,865 $108 Million
Q2 2023

Jul 25, 2023

SELL
$36.12 - $41.79 $790,883 - $915,033
-21,896 Reduced 0.65%
3,323,287 $122 Million
Q1 2023

May 17, 2023

BUY
$39.39 - $51.28 $128 Million - $166 Million
3,244,798 Added 3232.35%
3,345,183 $136 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $127 Million - $165 Million
-3,219,197 Reduced 96.98%
100,385 $4.1 Billion
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $8.37 Million - $10.9 Million
-200,420 Reduced 5.69%
3,319,582 $170 Million
Q3 2022

Nov 04, 2022

BUY
$43.76 - $53.42 $1.79 Million - $2.19 Million
40,933 Added 1.18%
3,520,002 $154 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $602,563 - $714,451
12,950 Added 0.37%
3,479,069 $182 Million
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $394,365 - $488,667
8,620 Added 0.25%
3,466,119 $179 Million
Q4 2021

Jan 31, 2022

SELL
$41.32 - $61.25 $3.34 Million - $4.95 Million
-80,775 Reduced 2.28%
3,457,499 $204 Million
Q3 2021

Oct 20, 2021

SELL
$39.25 - $50.42 $4.9 Million - $6.3 Million
-124,912 Reduced 3.41%
3,538,274 $152 Million
Q2 2021

Jul 20, 2021

SELL
$35.91 - $40.68 $6.27 Million - $7.1 Million
-174,583 Reduced 4.55%
3,663,186 $143 Million
Q1 2021

Apr 22, 2021

SELL
$33.49 - $37.77 $10.4 Million - $11.7 Million
-311,002 Reduced 7.5%
3,837,769 $139 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $4.2 Million - $5.35 Million
-125,619 Reduced 2.94%
4,148,771 $153 Million
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $11.2 Million - $13.2 Million
-353,269 Reduced 7.63%
4,274,390 $157 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $7.01 Million - $8.5 Million
-232,630 Reduced 4.79%
4,627,659 $151 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $2.27 Million - $3.25 Million
84,089 Added 1.76%
4,860,289 $159 Million
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $444,617 - $504,584
-13,506 Reduced 0.28%
4,776,200 $178 Million
Q3 2019

Nov 20, 2019

SELL
$32.49 - $42.13 $689,990 - $894,714
-21,237 Reduced 0.44%
4,789,706 $163 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $307,192 - $344,906
-8,307 Reduced 0.17%
4,810,943 $208 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $4.76 Million - $5.23 Million
-127,000 Reduced 2.57%
4,819,250 $196 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $6.78 Million - $7.73 Million
-176,345 Reduced 3.44%
4,946,250 $216 Million
Q3 2018

Oct 23, 2018

SELL
$34.47 - $41.81 $3.59 Million - $4.35 Million
-104,075 Reduced 1.99%
5,122,595 $226 Million
Q2 2018

Aug 02, 2018

SELL
$32.98 - $35.16 $3.25 Million - $3.47 Million
-98,570 Reduced 1.85%
5,226,670 $190 Million
Q1 2018

Apr 10, 2018

SELL
$31.91 - $37.02 $4.13 Million - $4.79 Million
-129,482 Reduced 2.37%
5,325,240 $189 Million
Q4 2017

Jan 22, 2018

SELL
$33.26 - $35.29 $1.4 Million - $1.49 Million
-42,167 Reduced 0.77%
5,454,722 $198 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $170 Million - $188 Million
5,496,889
5,496,889 $196 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.